Functional outcome after one year follow-up in cryptogenetic brain infarction and patent foramen ovale;Pronóstico funcional tras un año de seguimiento en pacientes con infarto cerebral de causa desconocida y foramen oval permeable

Medicina Clinica

Volumn 124, Issue 15, 2005, Pages 561-565

  Santamarina, Esteban ^a,b   Rubiera, Marta ^a   Molina, Carlos A ^a   González Alujas, M Teresa ^b   Evangelista, Arturo ^b   Muñoz, Verónica ^c   Rovira, Álex ^c   Quintana, Manuel ^a   Álvarez Sabín, José ^a  

^a Servicio de Neurologia   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Functional outcome; Patent foramen ovale; Stroke

Indexed keywords

ADULT; AGED; ANEURYSM; ARTICLE; BRAIN INFARCTION; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART ATRIUM SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; RATING SCALE; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 18844385736     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13074135     Document Type: Article

References (20)

1. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke. A meta-analysis of case-control studies. Neurology. 2000;55:1172-9.
2. Lucas C, Goullard L, Marchau M, Godefroy O, Rondepierre P, Chamas E, et al. Higher prevalence of atrial septal aneurysms in patients with ischemic strokes of unknown cause. Acta Neurol Scand. 1994;89:210-3.
3. Lechat P, Mas JL, Lascaut G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. NEJM. 1988; 318:1148-52.
4. Webster MWI, Chancelor AM, Smith HJ, Swift DL, Sharp DN, Bass NM. Patent foramen ovale in young stroke patients. Lancet. 1998;2:11-2.
5. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001; 345: 1740-6.
6. Murat Sumer M, Erturk O. Ischemic stroke subtypes: risk factors, functional outcome and recurrence. Neurol Sci. 2002;22:449-54.
7. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of functional outcome, survival and recurrence. Stroke. 2000; 3:1062-8.
8. Leys D, Bandu L, Hénon H, Lucas C, Mounier-Vehier F, Rondepierre P, et al. Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology. 2002;59: 26-33.
9. Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, Trystam D, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Stroke. 2002;33:706-11.
10. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically indentifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-6.
11. International Headache Society. Classification and diagnosis criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8:1-28.
12. Adams HP Jr, Bendixen BH, Kappelle U, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischaemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:2735.
13. Serena J, Segura T, Pérez-Ayuso MJ, Bassaganyas J, Molins A, Dávalos A. The need to quantify right-to-left cortocircuito in acute ischemis stroke. Stroke. 2000;31:2407-13.
14. Itoh H, Shioi M. Location of lesion on CT and motor functional outcome of the upper and lower limbs in patients with cerebral infarction. [abstract]. No To Shinkei. 1996;48:831-7
15. Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001;38:613-23.
16. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J. 1995;130: 1083-9.
17. Bougousslavsky J, Garazi S, Jeanrenaud X. Stroke recurrence in patients with patent foremen ovale: the Lausanne study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology. 1996;46:1301-5.
18. Nedeltchev K, Arnold M, Wahl A, Sturzeneger M, Vella EE, Windecker S, et al. Outcome of patients with cryptogenetic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry. 2002;72:347-50.
19. Schuchlenz HW, Weihs W, Horner S. The association between the diameter of a patent foramen ovale and the risk of embolia cerebrovascular events. Am J Med. 2000;109:456-62.
20. Homma S, Sacco R, Di Tullio M, Sciacco R, Mohr JP, for the PFO in Cryptogenetic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with PFO. Circulation. 2002;105:2625-31.